271 related articles for article (PubMed ID: 16980333)
21. [Anti-VGKC antibody-associated limbic encephalitis/Morvan syndrome].
Misawa T; Mizusawa H
Brain Nerve; 2010 Apr; 62(4):339-45. PubMed ID: 20420173
[TBL] [Abstract][Full Text] [Related]
22. Syndrome and outcome of antibody-negative limbic encephalitis.
Graus F; Escudero D; Oleaga L; Bruna J; Villarejo-Galende A; Ballabriga J; Barceló MI; Gilo F; Popkirov S; Stourac P; Dalmau J
Eur J Neurol; 2018 Aug; 25(8):1011-1016. PubMed ID: 29667271
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.
Malter MP; Elger CE; Surges R
Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046
[TBL] [Abstract][Full Text] [Related]
24. [Autoimmune limbic encephalitis: importance of early diagnosis and treatment].
van Vliet J; Meulstee J; Hartong EG; Mulleners WM
Ned Tijdschr Geneeskd; 2012; 156(16):A4455. PubMed ID: 22510418
[TBL] [Abstract][Full Text] [Related]
25. [VGKC-complex antibodies].
Watanabe O
Brain Nerve; 2013 Apr; 65(4):401-11. PubMed ID: 23568988
[TBL] [Abstract][Full Text] [Related]
26. [Limbic encephalitis and variants related to neuronal cell membrane autoantigens].
Dalmau J
Rinsho Shinkeigaku; 2008 Nov; 48(11):871-4. PubMed ID: 19198103
[TBL] [Abstract][Full Text] [Related]
27. Clinico-pathological correlation in adenylate kinase 5 autoimmune limbic encephalitis.
Ng AS; Kramer J; Centurion A; Dalmau J; Huang E; Cotter JA; Geschwind MD
J Neuroimmunol; 2015 Oct; 287():31-5. PubMed ID: 26439959
[TBL] [Abstract][Full Text] [Related]
28. Voltage-gated potassium channel-associated limbic encephalitis in the West of Scotland: case reports and literature review.
Reid JM; Foley P; Willison HJ
Scott Med J; 2009 Nov; 54(4):27-31. PubMed ID: 20034278
[TBL] [Abstract][Full Text] [Related]
29. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.
Lancaster E; Lai M; Peng X; Hughes E; Constantinescu R; Raizer J; Friedman D; Skeen MB; Grisold W; Kimura A; Ohta K; Iizuka T; Guzman M; Graus F; Moss SJ; Balice-Gordon R; Dalmau J
Lancet Neurol; 2010 Jan; 9(1):67-76. PubMed ID: 19962348
[TBL] [Abstract][Full Text] [Related]
30. Relative frequency of VGKC and 'classical' paraneoplastic antibodies in patients with limbic encephalitis.
Jarius S; Hoffmann LA; Stich O; Clover L; Rauer S; Vincent A; Voltz R
J Neurol; 2008 Jul; 255(7):1100-1. PubMed ID: 18574619
[No Abstract] [Full Text] [Related]
31. [Limbic encephalitis--evolving concepts].
Serratrice G; Pellissier JF; Serratrice J; De Paula A
Bull Acad Natl Med; 2008 Nov; 192(8):1531-41; discussion 1541-2. PubMed ID: 19445370
[TBL] [Abstract][Full Text] [Related]
32. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
Yamamoto T; Tsuji S
Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
[TBL] [Abstract][Full Text] [Related]
33. Limbic encephalitis with LGI1 antibodies in a 14-year-old boy.
Schimmel M; Frühwald MC; Bien CG
Eur J Paediatr Neurol; 2018 Jan; 22(1):190-193. PubMed ID: 28919330
[TBL] [Abstract][Full Text] [Related]
34. Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis.
Hansen N; Widman G; Witt JA; Wagner J; Becker AJ; Elger CE; Helmstaedter C
Epilepsy Behav; 2016 Dec; 65():18-24. PubMed ID: 27855355
[TBL] [Abstract][Full Text] [Related]
35. Voltage-gated potassium channel antibodies associated limbic encephalitis in a patient with invasive thymoma.
Ohshita T; Kawakami H; Maruyama H; Kohriyama T; Arimura K; Matsumoto M
J Neurol Sci; 2006 Dec; 250(1-2):167-9. PubMed ID: 17028029
[TBL] [Abstract][Full Text] [Related]
36. Potassium channel antibodies in two patients with reversible limbic encephalitis.
Buckley C; Oger J; Clover L; Tüzün E; Carpenter K; Jackson M; Vincent A
Ann Neurol; 2001 Jul; 50(1):73-8. PubMed ID: 11456313
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune limbic encephalitis with anti-contactin-associated protein-like 2 antibody secondary to pembrolizumab therapy.
Brown MP; Hissaria P; Hsieh AH; Kneebone C; Vallat W
J Neuroimmunol; 2017 Apr; 305():16-18. PubMed ID: 28284337
[TBL] [Abstract][Full Text] [Related]
38. Excellent outcome after prolonged status epilepticus due to non-paraneoplastic limbic encephalitis.
Kondziella D; Andersen O; Asztely F; Holmberg B; Hedström A; Szentgyörgyi E
Acta Neurol Belg; 2008 Mar; 108(1):21-3. PubMed ID: 18575183
[TBL] [Abstract][Full Text] [Related]
39. Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies.
Matà S; Muscas GC; Naldi I; Rosati E; Paladini S; Cruciatti B; Bisulli F; Paganini M; Mazzi G; Sorbi S; Tinuper P
J Neuroimmunol; 2008 Aug; 199(1-2):155-9. PubMed ID: 18586329
[TBL] [Abstract][Full Text] [Related]
40. Clinical analysis of anti-Ma2-associated encephalitis.
Dalmau J; Graus F; Villarejo A; Posner JB; Blumenthal D; Thiessen B; Saiz A; Meneses P; Rosenfeld MR
Brain; 2004 Aug; 127(Pt 8):1831-44. PubMed ID: 15215214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
